围手术期COVID-19内外科议题:保障外科医生、手术室团队与患者安全
本文介绍单中心学术医学中心制定的围手术期COVID-19方案,旨在在疫苗分发与疫情高峰阶段安全恢复择期手术。文中指出检测方案可减少病毒传播,但因假阴性检测及血清转换与症状出现前的较长潜伏期,COVID阳性患者仍可能未被检出而接受手术。有效机构策略不仅包括明确的围手术期检测方案,还应包括临床表现教育与暴露控制。
要点
- 检测方案可减少病毒传播,但假阴性与长潜伏期可致漏检。
- 安全恢复择期手术需机构层面制定围手术期COVID-19方案。
- 机构策略应兼顾检测方案、临床表现教育与暴露控制。
核心结论
- 有效机构策略不仅包括明确的围手术期检测方案,还应包括临床表现教育与暴露控制。
- 检测方案可减少病毒传播,但因假阴性与长潜伏期,COVID阳性患者仍可能未被检出而接受手术。
研究设计与样本
- 单中心学术医学中心围手术期COVID-19方案的描述性文章。
主要发现
- 检测方案有助于减少病毒传播。
- 因潜在假阴性检测及血清转换和症状出现前的较长潜伏期,COVID阳性患者仍可能未被检出而接受手术。
临床怎么用
- 医疗机构应制定围手术期COVID-19检测方案以支持安全恢复择期手术。
- 应同时开展临床表现教育与暴露控制,而不仅依赖检测方案。
局限性
- 本文为单中心学术医学中心方案描述,未报告检测效能、样本量或结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronavirus disease 2019 (COVID-19) has infected over 22 million people in the United States (US) and has had a devastating impact on the US economy and healthcare system. In order to help slow the spread of the virus and save hospital resources, nonessential businesses were forced to close and elective surgeries have been postponed. METHODS: As we reach the peak of the pandemic and the COVID-19 vaccine gets distributed, healthcare systems must develop plans to safely resume elective surgeries. This article outlines a single center academic medical center's perioperative COVID-19 protocol to help keep surgeons, operating room teams, and patients safe. RESULTS: While testing protocols can help minimize the transmission of the virus, there is still the potential for COVID+ patients to undergo surgery undetected, due to potential false negative tests and the long incubation period before seroconversion and symptom development. CONCLUSIONS: An effective institutional strategy not only includes clear perioperative testing protocols, but also education regarding clinical manifestations and exposure control.
引用
- Bonano JC, Huddleston JI. Perioperative Medical and Surgical Coronavirus Disease 2019 Issues: Keeping Surgeons, Operating Room Teams, and Patients Safe. J Arthroplasty. 2021. PMID: 33618956. doi:10.1016/j.arth.2021.01.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。